Prime Medicine, Inc.
corporate_fare Company Profile
Prime Medicine, Inc. (NASDAQ:PRME) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 26 items for PRME at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Prime Medicine Appoints Experienced Biotech CFO Svetlana Makhni Amidst Going Concern Warning
- Prime Medicine Discloses Substantial Doubt About Going Concern, Faces Arbitration Over Key Program
- Prime Medicine Files Amended Shelf Registration for $500M Securities, Including $200M ATM, Amidst Going Concern Warning
- Prime Medicine Posts $1.35 Loss Per Share for Full-Year 2025
- Prime Medicine Plans BLA Submission for PM359 in CGD, Advances Liver Programs to Clinic
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$4.63M
Net Income
-$201.14M
Diluted EPS
-$1.35
Op. Cash Flow
-$162.56M
Free Cash Flow
-$167.09M
Operating Income
-$208.35M
Cash & Equivalents
$63.03M
Debt / Equity
0.00×
Net Margin
-43.42×
Shares Outstanding
180.51M sh
Source: 10-K · filed 2026-03-03 · accession 0001628280-26-013569
show_chartPrice Chart
Loading chart...
feed PRME - Filings & News (Page 2)
PRME
Apr 16, 2026, 8:15 AM EDT
Price at Filing:
$3.83
Real-time Price:
$3.56
Change:
-$0.2657 (-7%)
Market Cap:
$645.821M
PRME
Mar 03, 2026, 8:19 AM EST
Price at Filing:
$4.39
Real-time Price:
$3.56
Change:
-$0.8269 (-19%)
Market Cap:
$645.821M
PRME
Mar 03, 2026, 8:13 AM EST
Price at Filing:
$4.39
Real-time Price:
$3.56
Change:
-$0.8269 (-19%)
Market Cap:
$645.821M
PRME
Mar 03, 2026, 8:04 AM EST
Price at Filing:
$4.40
Real-time Price:
$3.56
Change:
-$0.840 (-19%)
Market Cap:
$645.821M
PRME
Mar 03, 2026, 8:02 AM EST
Price at Filing:
$4.40
Real-time Price:
$3.56
Change:
-$0.840 (-19%)
Market Cap:
$645.821M
PRME
Jan 12, 2026, 8:31 AM EST
Price at Filing:
$4.07
Real-time Price:
$3.56
Change:
-$0.510 (-13%)
Market Cap:
$645.821M